Polypropylene vs Polyglactin in Suturing of the Lung

October 29, 2023 updated by: Ahmad Mohammad Younus, Assiut University
Comparative study comparing polypropylene and Polyglactin in suturing of the lung

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Lung tear or, pulmonary laceration is an injury in lung parenchyma, said injury can be caused by several reasons:

Blunt chest trauma Penetrating trauma such as stab wounds or firearm wounds Iatrogenic, such as faulty intercostal tube insertion

Study Type

Observational

Enrollment (Estimated)

100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All patients presented to cardiothoracic surgery department and trauma department with the inclusion criteria applied

Description

Inclusion Criteria:

  • Patients admitted to Assiut University Hospital And will undergo surgery for lung tear repair.
  • Patients admitted to Assiut University Hospital And will undergo surgery for bullectomy or lobectomy.

Exclusion Criteria:

  • Patients with lung injury repaired with a stapler

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Polyglactin group
lung suturing with polyglactin
Procedure: lung suturing with polyglactin
lung suturing with polyglactin
Polypropylene Arm
lung suturing with Polypropylene
Procedure: ung suturing with polypropylene
ung suturing with polypropylene

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
duration in days of intercostal tube air leak with each group
Time Frame: 2 weeks
Polypropylene vs Polyglactin
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 15, 2024

Primary Completion (Estimated)

April 30, 2026

Study Completion (Estimated)

October 30, 2028

Study Registration Dates

First Submitted

October 11, 2023

First Submitted That Met QC Criteria

October 29, 2023

First Posted (Estimated)

November 3, 2023

Study Record Updates

Last Update Posted (Estimated)

November 3, 2023

Last Update Submitted That Met QC Criteria

October 29, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • polyglactin lung suturing

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on lung suturing with polyglactin

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe